
Therapeutic Review4 min read
COPD Beyond Inhalers
Can biologics reach more patients? IL-33 inhibition may extend exacerbation prevention beyond eosinophil-selected trials, but important questions remain.
Read articleBrowse Medeasy Review articles focused on Pulmonology.

Can biologics reach more patients? IL-33 inhibition may extend exacerbation prevention beyond eosinophil-selected trials, but important questions remain.
Read article